1. Home
  2. VSTM vs AMBC Comparison

VSTM vs AMBC Comparison

Compare VSTM & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • AMBC
  • Stock Information
  • Founded
  • VSTM 2010
  • AMBC 1971
  • Country
  • VSTM United States
  • AMBC United States
  • Employees
  • VSTM N/A
  • AMBC N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • AMBC Property-Casualty Insurers
  • Sector
  • VSTM Health Care
  • AMBC Finance
  • Exchange
  • VSTM Nasdaq
  • AMBC Nasdaq
  • Market Cap
  • VSTM 425.9M
  • AMBC 411.3M
  • IPO Year
  • VSTM 2012
  • AMBC 1991
  • Fundamental
  • Price
  • VSTM $6.14
  • AMBC $8.82
  • Analyst Decision
  • VSTM Strong Buy
  • AMBC Strong Buy
  • Analyst Count
  • VSTM 9
  • AMBC 2
  • Target Price
  • VSTM $12.63
  • AMBC $12.50
  • AVG Volume (30 Days)
  • VSTM 2.5M
  • AMBC 1.2M
  • Earning Date
  • VSTM 08-07-2025
  • AMBC 08-04-2025
  • Dividend Yield
  • VSTM N/A
  • AMBC N/A
  • EPS Growth
  • VSTM N/A
  • AMBC N/A
  • EPS
  • VSTM N/A
  • AMBC N/A
  • Revenue
  • VSTM $10,000,000.00
  • AMBC $253,912,000.00
  • Revenue This Year
  • VSTM $81.24
  • AMBC N/A
  • Revenue Next Year
  • VSTM $408.06
  • AMBC $17.41
  • P/E Ratio
  • VSTM N/A
  • AMBC N/A
  • Revenue Growth
  • VSTM N/A
  • AMBC 125.08
  • 52 Week Low
  • VSTM $2.10
  • AMBC $5.99
  • 52 Week High
  • VSTM $9.10
  • AMBC $13.64
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 66.83
  • AMBC 71.42
  • Support Level
  • VSTM $4.86
  • AMBC $8.52
  • Resistance Level
  • VSTM $5.62
  • AMBC $9.05
  • Average True Range (ATR)
  • VSTM 0.38
  • AMBC 0.41
  • MACD
  • VSTM 0.18
  • AMBC 0.16
  • Stochastic Oscillator
  • VSTM 91.23
  • AMBC 89.45

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About AMBC Ambac Financial Group Inc.

Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.

Share on Social Networks: